Literature DB >> 15201427

Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.

Philipp Ströbel, Martina Hartmann, Andreas Jakob, Kristina Mikesch, Ingo Brink, Stefan Dirnhofer, Alexander Marx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15201427     DOI： 10.1056/NEJM200406173502523

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  43 in total

Review 1.  Targeted therapy for cancer: the gastrointestinal stromal tumor model.

Authors:  Vinod P Balachandran; Ronald P Dematteo
Journal:  Surg Oncol Clin N Am       Date:  2013-07-24       Impact factor: 3.495

Review 2.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.

Authors:  Daniel R Principe; Suneel D Kamath; Hidayatullah G Munshi; Nisha A Mohindra
Journal:  Oncologist       Date:  2019-11-01

4.  Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.

Authors:  Thomas Neuhaus; Joachim Luyken
Journal:  Target Oncol       Date:  2012-10-23       Impact factor: 4.493

5.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

6.  Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience.

Authors:  P Ströbel; R Bargou; A Wolff; D Spitzer; C Manegold; A Dimitrakopoulou-Strauss; L Strauss; C Sauer; F Mayer; P Hohenberger; A Marx
Journal:  Br J Cancer       Date:  2010-06-22       Impact factor: 7.640

Review 7.  Treatment of advanced thymoma and thymic carcinoma.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Curr Treat Options Oncol       Date:  2009-04-21

8.  Treatment updates in advanced thymoma and thymic carcinoma.

Authors:  Matthew A Gubens
Journal:  Curr Treat Options Oncol       Date:  2012-12

9.  Comparison of patterns of relapse in thymic carcinoma and thymoma.

Authors:  James Huang; Nabil P Rizk; William D Travis; Gregory J Riely; Bernard J Park; Manjit S Bains; Joseph Dycoco; Raja M Flores; Robert J Downey; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07       Impact factor: 5.209

10.  Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

Authors:  Nicolas Girard; Ronglai Shen; Tianhua Guo; Maureen F Zakowski; Adriana Heguy; Gregory J Riely; James Huang; Christopher Lau; Alex E Lash; Marc Ladanyi; Agnes Viale; Cristina R Antonescu; William D Travis; Valerie W Rusch; Mark G Kris; William Pao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.